About
Generics
Areas of Focus
Categories
Generic DrugIndia
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
0
As Collaborator
2
Total Enrollment
650
By Phase
EARLY_PHASE1: 1PHASE3: 1
By Status
ACTIVE_NOT_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT06272253Collaborator
UNAIR Inactivated COVID-19 Vaccine INAVAC as Heterologue Booster (Immunobridging Study) in Adolescent Subjects
EARLY_PHASE1Active, not recruiting
250 participants
Started: Sep 19, 2023 · Completed: Jul 19, 2024
NCT06282692Collaborator
INAVAC Vaccine Phase III (Immunobridging Study) in Healthy Population Aged 12 to 17 Years Old
PHASE3Recruiting
400 participants
Started: Jun 19, 2023 · Completed: Jul 19, 2024
Locations (1)
Headquarters
Nalagarh, India
Map
Loading map...